REFERENCES

• JohnstoneECCrowTJ.FrithCD.HusbandJ.KreelL.Cerebral ventricular size and cognitive impairment in chronic schizophrenia.Lancet.1976292492662160
   PubMed Web of Science ®Google Scholar
• KlöppelS.StonningtonCM.ChuC.et al.Automatic classification of MR scans in Alzheimer's disease.Brain.2008131Pt 368168918202106
   PubMedGoogle Scholar
• TeipelS.DrzezgaA.GrotheMJ.et al.Multimodal imaging in Alzheimer's disease: validity and usefulness for early detection.Lancet Neurol.201514101037105326318837
   PubMed Web of Science ®Google Scholar
• VemuriP.SimonG.KantarciK.et al.Antemortem differential diagnosis of dementia pathology using structural MRI: Differential-STAND.Neuroimage.201155252253121195775
   PubMed Web of Science ®Google Scholar
• TeipelSJ.KurthJ.KrauseB.GrotheMJ.Alzheimer's Disease neuro-imaging initiative. The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - beyond classical regression.Neuroimage Clin.2015858359326199870
   PubMed Web of Science ®Google Scholar
• StephanBC.TzourioC.AuriacombeS.et al.Usefulness of data from magnetic resonance imaging to improve prediction of dementia: population-based cohort study.BMJ.2015350h286326099688
   PubMedGoogle Scholar
• ZhangS.SmailagicN.HydeC.et al.(11)C-PIB-PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).Cochrane Database Syst Rev.20147CD010386
   Google Scholar
• RiceL.BisdasS.The diagnostic value of FDG and amyloid PET in Alzheimer's disease-A systematic review.Eur J Radiol.201794162428941755
   PubMed Web of Science ®Google Scholar
• WatkinsCC.SawaA.PomperMG.Glia and immune cell signaling in bipolar disorder: insights from neuropharmacology and molecular imaging to clinical application.Transl Psychiatry.20144e35024448212
   PubMed Web of Science ®Google Scholar
• JuddLL.AkiskalHS.SchettlerPJ.et al.Psychosocial disability in the course of bipolar I and II disorders: a prospective, comparative, longitudinal study.Arch Gen Psychiatry.2005621213223016330720
   PubMed Web of Science ®Google Scholar
• AngstJ.PreisigM.Outcome of a clinical cohort of unipolar, bipolar and schizoaffective patients. Results of a prospective study from 1959 to 1985, (1985).Schweiz Arch Neurol Psychiatr.199514611723
   PubMedGoogle Scholar
• HallahanB.NewellJ.SoaresJC.et al.Structural magnetic resonance imaging in bipolar disorder: an international collaborative mega-analysis of individual adult patient data.Biol Psychiatry.201169432633521030008
   PubMed Web of Science ®Google Scholar
• HibarDP.WestlyeLT.DoanNT.et al.Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group.Mol Psychiatry.201823493294228461699
   PubMed Web of Science ®Google Scholar
• SchnackHG.NieuwenhuisM.van HarenNE.et al.Can structural MRI aid in clinical classification? A machine learning study in two independent samples of patients with schizophrenia, bipolar disorder and healthy subjects.Neuroimage.20148429930624004694
   PubMed Web of Science ®Google Scholar
• JieNF.ZhuMH.MaXY.et al.Discriminating bipolar disorder from major depression based on svm-foba: efficient feature selection with multimodal brain imaging data.IEEE Trans Auton Ment Dev.20157432033126858825
   PubMedGoogle Scholar
• SchmittA.MalchowB.HasanA.FalkaiP.The impact of environmental factors in severe psychiatric disorders.Front Neurosci.201481924574956
   PubMed Web of Science ®Google Scholar
• FangJ.MaoN.JiangX.et al.Functional and anatomical brain abnormalities and effects of antidepressant in major depressive disorder: combined application of voxel-based morphometry and amplitude of frequency fluctuation in resting state.J Comput Assist Tomogr.201539576677326125296
   PubMed Web of Science ®Google Scholar
• AgudeloC.AizensteinHJ.KarpJF.ReynoldsCF 3rd.Applications of magnetic resonance imaging for treatment-resistant late-life depression.Dialogues Clin Neurosci.201517215116926246790
   PubMed Web of Science ®Google Scholar
• JohnstonBA.SteeleJD.TolomeoS.ChristmasD.MatthewsK.Structural MRI-based predictions in patients with treatment-refractory depression (TRD).PLoS One.2015107e013295826186455
   PubMed Web of Science ®Google Scholar
• PatelMJ.AndreescuC.PriceJC.EdelmanKL.ReynoldsCF.AizensteinHJ.Machine learning approaches for integrating clinical and imaging features in late-life depression classification and response prediction.Int J Geriatr Psychiatry.201530101056106725689482
   PubMed Web of Science ®Google Scholar
• FalkaiP.RossnerM.SchulzeTG.et al.Kraepelin revisited: schizophrenia from degeneration to failed regeneration.Mol Psychiatry.201520667167625824303
   PubMed Web of Science ®Google Scholar
• van ErpTG.HibarDP.RasmussenJM.et al.Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium.Mol Psychiatry.201621454755326033243
   PubMed Web of Science ®Google Scholar
• Fusar-PoliP.Meyer-LindenbergA.Forty years of structural imaging in psychosis: promises and truth.Acta Psychiatr Scand.2016134320722427404479
   PubMed Web of Science ®Google Scholar
• KoutsoulerisN.MeisenzahlEM.BorgwardtS.et al.Individualized differential diagnosis of schizophrenia and mood disorders using neuroanatomical biomarkers.Brain.20151382059207325935725
   PubMed Web of Science ®Google Scholar
• KoutsoulerisN.MeisenzahlEM.DavatzikosC.et al.Use of neuroanatomical pattern classification to identify subjects in at-risk mental states of psychosis and predict disease transition.Arch Gen Psychiatry.20096670071219581561
   PubMed Web of Science ®Google Scholar
• KoutsoulerisN.BorgwardtS.MeisenzahlEM.BottlenderR.MöllerHJ.Riecher-RösslerA.Disease prediction in the at-risk mental state for psychosis using neuroanatomical biomarkers: results from the FePsy study.Schizophr Bull.20123861234124622080496
   PubMed Web of Science ®Google Scholar
• KoutsoulerisN.WobrockT.GuseB.et al.Predicting response to repetitive transcranial magnetic stimulation in patients with schizophrenia using structural magnetic resonance imaging: a multisite machine learning analysis.Schizophr Bull. 2017. doi: 10.1093/schbul/sbx114. [Epub ahead of print]
   Google Scholar
• DazzanP.ArangoC.FleischackerW.et al.Magnetic resonance imaging and the prediction of outcome in first-episode schizophrenia: a review of current evidence and directions for future research.Schizophr Bull.201541357458325800248
   PubMed Web of Science ®Google Scholar
• SzeszkoPR.NarrKL.PhillipsOR.et al.Magnetic resonance imaging predictors of treatment response in first-episode schizophrenia.Schizophr Bull.201238356957821084552
   PubMed Web of Science ®Google Scholar
• KoutsoulerisN.KahnRS.ChekroudAM.et al.Multisite prediction of 4-week and 52-week treatment outcomes in patients with first-episode psychosis: a machine learning approach.Lancet Psychiatry.201631093594627569526
   PubMed Web of Science ®Google Scholar
• SchmittA.RujescuD.GawlikM.et al.Consensus paper of the WFSBP Task Force on Biological Markers: Criteria for biomarkers and endophenotypes of schizophrenia part II: Cognition, neuroimaging and genetics.World J Biol Psychiatry.20161764062827311987
   PubMed Web of Science ®Google Scholar
• SommerIE.de KortGA.MeijeringAL.et al.How frequent are radiological abnormalities in patients with psychosis? A review of 1379 MRI scans.Schizophr Bull.201339481581922416264
   PubMed Web of Science ®Google Scholar
• KuipersE.Yesufu-UdechukuA.TaylorC.KendallT.Management of psychosis and schizophrenia in adults: summary of updated NICE guidance.BMJ.2014348g117324523363
   PubMed Web of Science ®Google Scholar
• KahnRS.FleischhackerWW.BoterH.et al.Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomised clinical trial.Lancet.200837196181085109718374841
   PubMed Web of Science ®Google Scholar
• KimS.BirbaumerN.Real-time functional MRI neurofeedback: a tool for psychiatry.Curr Opin Psychiatry.201427533233625023886
   PubMed Web of Science ®Google Scholar
• ThibaultRT.MacPhersonA.LifshitzM.RothRR.RazA.Neurofeedback with fMRI: A critical systematic review.Neuroimage.201817278680729288868
   PubMed Web of Science ®Google Scholar
• YamadaT.HashimotoRI.YahataN.et al.Resting-state functional connectivity-based biomarkers and functional mri-based neurofeedback for psychiatric disorders: a challenge for developing theranostic biomarkers.Int J Neuropsychopharmacol.2017201076978128977523
   PubMed Web of Science ®Google Scholar
• CordesJS.MathiakKA.DyckM.et al.Cognitive and neural strategies during control of the anterior cingulate cortex by fMRI neurofeedback in patients with schizophrenia.Front Behav Neurosci.2015916926161073
   PubMed Web of Science ®Google Scholar
• Cohen KadoshK.LuoQ.et al.Using real-time fMRI to influence effective connectivity in the developing emotion regulation network.Neuroimage.201612561662626475487
   PubMed Web of Science ®Google Scholar
• KarchS.KeeserD.HümmerS.et al.Modulation of craving related brain responses using real-time fMRI in patients with alcohol use disorder.PLoS One.2015107e01330347
   Web of Science ®Google Scholar
• ScarrE.MillanMJ.BahnS.et al.Biomarkers for psychiatry: the journey from fantasy to fact, a report of the 2013 CINP Think Tank.Int J Neuropsychopharmacol.20151810pyv042.doi:10.1093/ijnp/pyv042.25899066
   PubMed Web of Science ®Google Scholar
• KapurS.PhillipsAG.InselTR.Why has it taken so long for biological psychiatry to develop clinical tests and what to do about it?Mol Psychiatry.201217121174117922869033
   PubMed Web of Science ®Google Scholar